Trials / Not Yet Recruiting
Not Yet RecruitingNCT06593834
A Clinical Study of Bacillus Coagulans in Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation
A Clinical Study of Bacillus Coagulans in Acute Graft-Versus-Host Disease (aGVHD) After Hematopoietic Stem Cell Transplantation
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 286 (estimated)
- Sponsor
- Yamin Fan · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the preventive effect of Bacillus coagulans on acute graft-versus-host disease (aGVHD) after hematopoietic stem cell transplantation
Detailed description
The study is conducted on patients after hematopoietic stem cell transplantation and the intervention is Bacillus coagulans, aiming to investigate the preventive effect of Bacillus coagulans on acute graft-versus-host disease after hematopoietic stem cell transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bacillus coagulans combined with the best treatment options for preventing aGVHD | BAT means the best treatment options for preventing aGVHD |
| DRUG | BAT | BAT |
Timeline
- Start date
- 2024-09-27
- Primary completion
- 2026-04-30
- Completion
- 2026-04-30
- First posted
- 2024-09-19
- Last updated
- 2024-09-25
Source: ClinicalTrials.gov record NCT06593834. Inclusion in this directory is not an endorsement.